Quidel | QDEL - Ebit



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 736.7M
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


Ebit 更改 日
Abbott USD 2.13B 281M 2026-06
Agilent USD 444M 45M 2026-06
Becton, Dickinson and Co. USD 752M 125M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.13B 217M 2026-06
Haemonetics USD 57.46M 80.48M 2026-06
Illumina USD 260M 21M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Neogen USD 3.1M 6.4M 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quidel USD -15.3M 12.1M 2026-06
Revvity USD 126.14M 43.36M 2026-06
STAAR Surgical USD 10.1M 7.3M 2026-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD 10M 138M 2026-06